INTRODUCTION
Quantitative real-time PCR (qPCR) is widely used for absolute or relative quanti®cation of gene expression, and is a critical tool for basic research, biotechnology and genetic diagnostics (1±3). This methodology is particularly suited because of its conceptual simplicity and practical ease (4) . The interpretation of ampli®cation curves rests on the existence of an exponentially growing phase in which the PCR ef®ciency E (here de®ned as the factor by which the amplicon concentration is multiplied at each cycle) should be theoretically constant and equal to 2. For some undemonstrated reasons, the ef®ciency is, in most systems, signi®cantly lower than 2. Current methods for relative and absolute quanti®cation in qPCR have been developed to take this deviation into account (5±7). On the other hand, the non-exponential phase and the plateau of the ampli®cation curve are either not considered in these methods, or are described by a phenomenological model (8) which does not explain the non-exponential shape of the curve. A progressive decrease of ef®ciency necessarily re¯ects a decline of DNA polymerase activity. It may result either from a true molecular inhibition (enzyme instability, inhibition by end product, etc.), or from a lack of factors required by the PCR to proceed (depletion of primers or of¯uorescent probe, template unavailability due to incomplete denaturation or to product reannealing, etc.). Apart from early experiments which were unable to explain the plateau by a single factor (9) , it has been more recently proposed that the main factor contributing to the plateau phase consists of the binding of DNA polymerase to its ampli®cation products (10) . The aim of our work was to further investigate the plateau effect. The unexpected outcome of our ®ndings is that the interpretation of the plateau value may serve to calibrate the signal¯uorescence. The useful consequence of this internal calibration is that the analysis of an ampli®cation curve may lead to the absolute quanti®cation of gene expression without the need for any calibration curve constructed with DNA plasmid standard samples.
MATERIALS AND METHODS

Real-time PCR
Using the Primer Express software program (Applied Biosystems), we designed PCR primers and probes (Eurogentec) for the ampli®cation of DNA derived from three different transcripts. (i) Insulin-like growth factor (IGF1): accession number, EMBL X04480; forward primer, GCTCCGGAAGCAACACTCA; reverse primer, GCTATGGCTCCAGCATTCG; probe, CCACAATGCC-TGTCTGAGGTGCCCT. (ii) Caveolin1 (CAV1): accession  number, EMBL AK057982; forward primer, AGCTGA-GGCAGAAGCAAGTGT; reverse primer, TGTTTAGG-TCGCGGTTGAC; probe, ACGCGCACACCAAGGA-GATCGAC. (iii) RAP1-GTPase-activating protein 1 (RAP1GA1): accession number, EMBL BC054490; forward primer, GCCCAAGTCGGAGAACTCATC; reverse primer, TGCGGTCTCCGCTCTGTT; probe, CCCCAGAGATG-CCCACGACCA.
Taqman probes carried a 5¢ FAM reporter label and a 3¢ DABCYL quencher group. The enzyme was activated by heating for 10 min at 95°C. A two-step PCR procedure was used, 60 s at 60°C and 15 s at 95°C for 50 cycles in a PCR mix containing 2 ml of cDNA template, 1Q qPCR Mastermix (RT-QP2X-03, Eurogentec), 300 nM of each primer and 100 nM probe in a total volume of 30 ml (except where otherwise stated). The¯uorescence intensity of the reporter label was normalized to the rhodamine derivative ROX as a passive reference label present in the buffer solution. The system generated a kinetic ampli®cation plot based upon the normalized¯uorescence. All reactions were performed in an AbiPrism 7700 (Applied Biosystems).
In order to demonstrate the aetiology of the plateau, a slight modi®cation of the protocol was applied. After 35 cycles, the reaction was stopped and a further addition of 1 ml containing either water, 1.55 mM probe (50 nM ®nal) or 27.9 mM primers (900 nM ®nal) was done before restarting the reaction for 15 more cycles.
Plasmid preparation
IGF1 cDNA was obtained from mouse thyroid RNA extract. Plasmids containing IGF1 cDNA (pCR 2.1), CAV1 cDNA (pIRES CAV1 puro, kindly provided by Dr S. Costagliola) and RAP1GA1 cDNA (pMT2-HA-RG glu, kindly provided by Dr F. Zwartkruis) were linearized by restriction with XbaI, EcoRI and SalI, respectively. The copy number was estimated by optical density according to the exact molar mass derived from the plasmidic and the amplicon sequences. Different dilutions were made to obtain 10 2 , 10 3 , 10 4 , 10 5 and 10 6 copies in 2 ml.
Dilution curve construction
Serially diluted samples (dilution factors of 1, 10, 100, 1000 and 10 000) were submitted to a qPCR run. The C t values were estimated at a threshold value of 0.1, which was at least twice as high as the detection limit corresponding to 10 times the value of the standard deviation of the¯uorescences in cycles 1±10.
RESULTS
In an attempt to question the proposal (10) that the plateau results from a complete molecular inhibition of the polymerase, an experiment was designed to test whether a further addition of a limiting factor at the time when the plateau was reached was capable of reinitiating the ampli®cation process. When a cDNA sample was ampli®ed by qPCR using 900 nM of primers and 50 nM of¯uorescent Taqman probe which hybridized to the IGF1 sequence, the ampli®cation curve reached a plateau after about 30 cycles (curves a±c in Fig. 1 ). After 35 cycles, the qPCR run was interrupted to allow a further addition of a ®nal probe concentration of 50 nM. As shown in Figure 1 , the probe supplement led to an additional ampli®cation which converged on the plateau obtained with an initial probe concentration of 100 nM (compare curves a and d in Fig. 1 ). These results demonstrate that, under these commonly used qPCR conditions, the plateau of the ampli®cation curve is due to the depletion of a limiting factor (here the¯uorescent probe) and not to any intrinsic loss of Taq polymerase activity.
Usually, an ampli®cation curve is described by the normalized¯uorescence increment DR n associated with the free¯uorophore release during probe hydrolysis. The subtracted background level, which is due to the partially quenched¯uorescence of the probe-bound¯uorophore, is thus dependent on the sample probe concentration. The fact that different probe concentrations were used in our experimental design required that the results of Figure 1 were described by the crude normalized¯uorescence R n (no background subtraction). A quantitative look at curves a and d con®rms that both the initial and the plateau values of thē uorescence, hence their difference DR n,plateau , are proportional to the total probe concentration. Knowing the probe concentration, an apparent speci®c¯uorescence Df of the incremental signal DR n can be estimated:
In fact, Df represents the difference between the speci®c uorescence of the free¯uorophore and the speci®c¯uores-cence of the probe-bound¯uorophore. The measured incremental signal DR n can be converted into the corresponding concentration of hydrolysed probe, at any cycle:
[probe] hydrolysed = DR n /Df 2
As far as the synthesis of one amplicon molecule is accompanied by the hydrolysis of one probe molecule, equation 2 can be rewritten:
This strict parallelism between amplicon synthesis and probe hydrolysis happens if template elongation starts after the hybridization of probe to template. This should be the case at least in the exponential phase of the ampli®cation where most of the probe molecules are still available, and for a probe for Figure 1 . Two-step qPCR allowing two successive additions of a limiting factor. Each sample initially contained primer concentrations of 900 nM and probe concentrations of 50 nM (samples a±c) or 100 nM (sample d) in a volume of 30 ml. Baseline¯uorescence was not subtracted from the measured R n¯u orescence. The ®rst qPCR run was stopped after 35 cycles. A further 1 ml volume of water was added to each sample. It contained a ®nal concentration of 50 nM probe in sample a, and a ®nal concentration of 900 nM primers in sample c. A second qPCR run of 15 cycles was then started. Only sample a, in which the probe concentration was increased, showed signi®cantly rising¯uorescence in the second run. which a high T m value ensures an ef®cient hybridization. If this is the case, the absolute initial target cDNA concentration in the sample can be directly estimated by the ratio between the chemical concentration of amplicon exponentially produced after n cycles (equation 3), and the ampli®cation factor which is, in the exponential phase, equal to E n :
[cDNA] initial = (DR n /Df)/E n 4
Alternatively, one may prefer to characterize the target cDNA content in the sample by the initial copy number. Equation 4 and the explicit formulation of Df lead to
where V and N 0 are the sample volume and the Avogadro's number, respectively. Equation 5, which is valid for any detectable DR n value belonging to the exponential phase, shows that the calculation of the initial copy number just requires a single ampli®cation curve obtained with a known and limiting probe concentration, and the ef®ciency value. Theoretically, the ef®ciency can be estimated by analysing the exponential phase of the same single ampli®cation curve (6, 7, 11) . However, when applying such an approach to our systems, we previously experienced very inaccurate ef®ciency estimates, simply because the exponential phase of most of our ampli®cation curves did not contain more than three or four points above the background level. We have thus preferred to estimate the ef®ciency by analysing the slope of a dilution curve constructed in a preliminary experiment in which C t values were determined from serially diluted samples (12) . It must be stressed that this latter strategy does not require samples with a known amount of target DNA, since the dilution curve is only referring to sample dilution factors. Thus, the use of samples for which the target cDNA content will be determined should ensure a relevant estimate of PCR ef®ciency. The robustness of the proposed method based on equation 5 has been tested by analysing qPCR curves obtained with samples containing known concentrations of cloned IGF1 DNA. However, these samples have been treated and analysed by our method as if their respective DNA contents were unknown. A ®rst preliminary experiment was performed for estimating the PCR ef®ciency: ®ve serially diluted samples (in decuple) were submitted to a qPCR run (Fig. 2a) and the dilution curve, constructed on the basis of the C t values estimated at a threshold of 0.1, was analysed by linear regression, which led to an ef®ciency estimate of 1.938 (Fig. 2b) with the 95% con®dence interval (CI) being 1.920± 1.957. Each qPCR curve was then separately analysed to estimate the initial target DNA content of the corresponding sample: equation 5 was applied to the data point displaying the lowest detectable¯uorescence signals (the detection limit being set to 10 times the standard deviation of the baselinē uorescence), and the resulting estimate of copy number was compared with the expected value (which was derived from the OD measurement of the plasmid preparation). In order to visualize the reliability of the results, a graphical representation was elaborated: equation 5 was repeatedly applied to all the data points of an ampli®cation curve (as if they all were detectable and situated in the exponential phase characterized by the previously estimated ef®ciency of 1.938), and the result was plotted against the cycle number (Fig. 2c) . The plot showed scattered values as long as the¯uorescence level was below the detection limit, followed by a plateau value obtained with the detectable points of the exponential phase. At higher cycle number values, the points progressively deviated from the plateau since they were obtained assuming a constant ef®ciency of 1.938, which led to an overestimated ampli®cation factor. The plateau value that such a plot unveils represents the copy number estimate of the sample. Figure 2c shows, for each dilution condition, the two curves leading to The data obtained in Figure 2 were also analysed by the classical method which used a calibration curve constructed by serially diluting the sample containing the known OD measured concentration of IGF1 DNA (Table 1) . Then, each individual sample was considered as unknown. Since the same samples were used as standard points and unknowns, the copy numbers estimated by the classical method had to converge in average on the expected value, as was in fact observed (compare columns 1 and 2 of Table 1 ). Both classical and proposed methods led to similarly dispersed copy number estimates with coef®cients of variation lower than 30% (compare the standard deviations of columns 2 and 3 of Table 1 ). The estimate means obtained by the proposed method showed a systematic deviation of~15% from the expected values. However, this deviation could be explained by the uncertainty of the ef®ciency estimate: taking the 95% CI for the ef®ciency estimate into account, it appeared that the corresponding CI for the copy number estimates extended over the expected copy number, with an exception in the case of the highest copy number value (see last column of Table 1 ). The observation that the upper limit of the CI was about twice the lower limit conformed with a C t uncertainty of about 1 unit.
Several other systems consisting of different DNA targets were analysed according to the same strategy. In most cases, the proposed method signi®cantly underestimated and never overestimated the target DNA content determined by OD measurement. Table 2 reports the results obtained with two particular systems: the representative CAV1 system which showed a moderate deviation of 30% from the expected values, and the RAP1GA1 system which more deeply underestimated the expected values by~75%. After checking that such deviations could not always be explained by errors of ef®ciency estimate, we considered the possibility that the experimental systems would not ful®l the two theoretical constraints involved in the proposed method, namely in the exponential phase of the ampli®cation process, (i) the synthesis of one amplicon molecule must be accompanied by the hydrolysis of one probe molecule; and (ii) the primers should hybridize to the whole target content. To check the ful®lment of these constraints, we had to demonstrate that neither the probe nor the primers were limiting factors, at least during the exponential phase of the ampli®cation. We thus veri®ed that the¯uorescence levels of the few measurable points in the exponential phase were not dependent on the concentrations of probe and primers. Figure 3 shows a typical result obtained with samples containing 10 6 copies of RAP1GA1 DNA for which the detectable exponential phase The classical method converted the C t value (obtained at a threshold value of 0.1) into the copy number (column 2) by using the calibration curve constructed with standard samples obtained by serial dilutions of a sample for which the DNA content was determined by OD measurement (column 1). The proposed method calculated the copy number by applying equation 5 to the points of the exponential phase for which the¯uorescence level exceeded the detection limit of 0.05, i.e. 10 times the value of the standard deviation of the¯uorescences in cycles 1±10. The copy number estimates (column 3) were calculated using an ef®ciency value of 1.938 (as obtained in Fig. 2b ). The last column represents the 95% CI as obtained by using the corresponding interval for the ef®ciency estimate. Table 2 . Comparison of the proposed method and the classical method based on the analysis of 50 ampli®cation curves obtained either with CAV1 DNA or RAP1GA1 DNA, according to the same protocol as that used with IGF1 DNA (see Table 1 was achieved in cycles 18±20. For these cycles, the increase of probe and primer concentrations did not signi®cantly enhance the¯uorescence levels, with a minor exception at cycle 20 where a small increase was observed at the highest probe concentrations. These results con®rmed that probe and primers were not limiting and that the experimental systems ful®lled the constraints of our methodology.
DISCUSSION
Quantitative real-time PCR is a tool of choice to estimate the absolute or relative amount of a target cDNA. Up to now, an absolute quanti®cation, when needed, required the construction of a calibration curve based on PCR results obtained with samples for which the amount of target DNA is known (13) . For that purpose, DNA-containing plasmids should be acquired, with obvious practical and economical inconvenience. Moreover, the reliability of such an approach rests on the high purity of the standard samples, since the calibration of the method is based on the determination of the target DNA content by OD measurement, which can be biased by the presence of contaminating DNA. An alternative possibility to this approach would be to determine the speci®c¯uorescence of the used¯uorophore in order to convert the qPCR uorescent signal into the produced amount of amplicon. Such a strategy was very recently proposed (12) but, again, standard samples containing known amounts of target DNA were required to determine the speci®c¯uorescence. On the contrary, our approach proposes to infer the speci®c¯uores-cence from the sole ampli®cation curve and in the appropriate experimental conditions of the qPCR run. This useful methodological improvement results from the ®nding that the plateau of the ampli®cation curve is due to the depletion of the¯uorescent TaqMan probe, and not to any amplicon accumulation-dependent inhibition of Taq polymerase (10) . In this case, the calibration of the assay rests on the accurate determination of the probe concentration based on the OD measurement of the available pure probe sample. Thus, bias in the calibration procedure used in our approach can be easily avoided. The accuracy with which the DNA copy number can be determined is mainly dependent on the CI of the ef®ciency estimate. We can propose, as a rule of thumb, that the copy number estimate may be biased, at worst, by a factor of 2, and that the imprecision is characterized by a maximal variation of 30% between identical samples. Last but not least, the method presents the economical advantage of requiring a low concentration of probe to ensure that a plateau is reached within a minimum number of ampli®cation cycles. 
